Roberto Feliu-Maldonado

Roberto Feliu-Maldonado

Auto-generated profile, based on publicly available information

Roberto Feliu-Maldonado

Research Centers in Minority Institutions Program, Center for Collaborative Research in Health Disparities, Academic Affairs Deanship, University of Puerto Rico, Medical Sciences Campus, San Juan 00936, Puerto Rico

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Stroke Research and Treatment
Verified
Journal Article
Open access
PDF file
AGAriel F. Gonzalez-Cordero
Ariel F. Gonzalez-Cordero
Jorge DucongeJorge Duconge
Jorge Duconge
HFHilton Franqui-Rivera
Hilton Franqui-Rivera
RFRoberto Feliu-Maldonado
Roberto Feliu-Maldonado
ARAbiel Roche-Lima
Abiel Roche-Lima
IAIsrael Alexis Almodovar-Rivera
Israel Alexis Almodovar-Rivera
Non-Hispanic whites present with higher atrial fibrillation (AF) prevalence than other racial minorities living in the mainland USA. In two hospital-based studies, Puerto Rican Hispanics had a lower prevalence of atrial fibrillation of 2.5 than non-Hispanic Whites with 5.7. This data is particularly controversial because Hispanics possess a higher prevalence of traditional risk factors for developing AF yet have a lower AF prevalence. This phenomenon is known as the atrial fibrillation paradox. Despite recent advancements in understanding AF, its pathogenesis remains unclear. In this study, we compared a genetic dataset of Puerto Rican Hispanics to 111 SNP known to be associated with AF in a large European cohort and determine if they are associated with AF susceptibility in our cohort. To achieve this aim, we performed a secondary analysis of existing data using the following two studies: (1) The Pharmacogenetics of Warfarin in Puerto Ricans study and the (2) A Genomic Approach for Clopidogrel in Caribbean Hispanics, and assess for the presence of European SNPs associated with AF from the genome-wide association study of 1 million people identifies 111 loci for atrial fibrillation. We used data from 555 cardiovascular Puerto Rican Hispanic patients, consisting of 486 control and 69 cases. We found that the following SNPs showed significant association with AF in PHR: rs2834618, rs6462079, rs7508, rs2040862, and rs10458660. Some of these SNPs are proteins involved in lysosomal activities responsible for breaking ceramides to sphingosines and collagen deposition around atrial cardiomyocytes. Furthermore, we performed a machine learning analysis and determined that Native American admixture and heart failure were strongly predictive of AF in PHR. For the first time, this study provides some genetic insight into AFs mechanisms in a Puerto Rican Hispanic cohort.

17 September 2023 in Genes
Verified
Journal Article
Open access
PDF file
MMMariangeli Monero-Paredes
Mariangeli Monero-Paredes
RFRoberto Feliu-Maldonado
Roberto Feliu-Maldonado
KCKelvin Carrasquillo-Carrion
Kelvin Carrasquillo-Carrion
PGPablo Gonzalez
Pablo Gonzalez
Igor B RogozinIgor B Rogozin
Igor B Rogozin
Jorge DucongeJorge Duconge
Jorge Duconge
Cardiovascular disease (CVD) is one of the leading causes of death in Puerto Rico, where clopidogrel is commonly prescribed to prevent ischemic events. Genetic contributors to both a poor clopidogrel response and the severity of CVD have been identified mainly in Europeans. However, the non-random enrichment of single-nucleotide polymorphisms (SNPs) associated with clopidogrel resistance within risk loci linked to underlying CVDs, and the role of admixture, have yet to be tested. This study aimed to assess the possible interaction between genetic biomarkers linked to CVDs and those associated with clopidogrel resistance among admixed Caribbean Hispanics. We identified 50 SNPs significantly associated with CVDs in previous genome-wide association studies (GWASs). These SNPs were combined with another ten SNPs related to clopidogrel resistance in Caribbean Hispanics. We developed Python scripts to determine whether SNPs related to CVDs are in close proximity to those associated with the clopidogrel response. The average and individual local ancestry (LAI) within each locus were inferred, and 60 random SNPs with their corresponding LAIs were generated for enrichment estimation purposes. Our results showed no CVD-linked SNPs in close proximity to those associated with the clopidogrel response among Caribbean Hispanics. Consequently, no genetic loci with a dual predictive role for the risk of CVD severity and clopidogrel resistance were found in this population. Native American ancestry was the most enriched within the risk loci linked to CVDs in this population. The non-random enrichment of disease susceptibility loci with drug-response SNPs is a new frontier in Precision Medicine that needs further attention.

1 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMariangeli Monero-Paredes
Mariangeli Monero-Paredes
RFRoberto A Feliu-Maldonado
Roberto A Feliu-Maldonado
KCKelvin Carrasquillo-Carrion
Kelvin Carrasquillo-Carrion
PGPablo Gonzalez-Santiago
Pablo Gonzalez-Santiago
Igor B RogozinIgor B Rogozin
Igor B Rogozin
Jorge DucongeJorge Duconge
Jorge Duconge
Cardiovascular disease (CVD) is one of the leading causes of death in Puerto Rico, where clopidogrel is commonly prescribed to prevent ischemic events. Genetic contributors to both a poor clopidogrel response and the severity of CVD have been identified mainly in Europeans. However, the non-random enrichment of single nucleotide polymorphisms (SNPs) associated with clopidogrel resistance within risk loci linked to underlying CVDs, and the role of admixture, has yet to be tested. This study aimed to assess possible interaction between genetic biomarkers linked to CVDs and those associated with clopidogrel resistance among admixed Caribbean Hispanics. We identified 50 SNPs significantly associated with CVDs in previous genome-wide association studies (GWAS). These SNPs were combined with another ten SNPs related to clopidogrel resistance in Caribbean Hispanics. We developed Python scripts to determine whether SNPs related to CVDs are in close proximity to those associated with clopidogrel response. Average and individual local ancestry (LAI) within each locus were inferred, and 60 random SNPs with their corresponding LAI were generated for enrichment estimation purposes. Our results showed no CVD-linked SNPs in close proximity to those associated with clopidogrel response among Caribbean Hispanics. Consequently, no genetic loci with a dual predictive role for risk of CVD severity and clopidogrel resistance were found in this population. Native American ancestry was the most enriched within risk loci linked to CVDs in this population. Non-random enrichment of disease susceptibility loci with drug response SNPs is a new frontier in Precision Medicine that needs further attention.